Role of complement activation and antibody in the interaction between Mycobacterium tuberculosis and human macrophages

Indian Journal of Experimental Biology

Volumn 50, Issue 8, 2012, Pages 542-550

  Manivannan, S ^a,b   Narayan Rao, V ^a   Ramanathan, V D ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b MADURAI KAMARAJ UNIVERSITY   (India)

Author keywords

Complement; Immunoglobulin; M. tuberculosis; Phagocytosis

Indexed keywords

ADULT; ARTICLE; COMPLEMENT ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; HUMAN; MACROPHAGE; MALE; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; COMPLEMENT ACTIVATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS;

BACILLI (CLASS); CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 84864815943     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. World Health Organization, Groups at risk: WHO report on the tuberculosis epidemic 2009. Geneva: World Health Organization; Global tuberculosis control-epidemiology, strategy, financing; WHO Report 2009 WHO/HTM/TB/2009:411. Available at http://www.who.int/tb/publications/global_report/2009/en/
2. Ernst J D, Macrophage receptors for Mycobacterium tuberculosis, Infect Immun, 66 (1998) 1277.
3. Kinoshita T, Takata Y, Kozono H, Takeda J, Hong K S & Inoue K, C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme, J Immunol, 141 (1998) 3895.
4. Arnaout M A, Structure and function of the leukocyte adhesion molecules CD11/CD18, Blood, 75 (1990) 1037.
5. Zaffran Y, Zhang L & Ellner J J, Role of CR4 in Mycobacterium tuberculosis-human macrophages binding and signal transduction in the absence of serum, Infect Immun, 66 (1998) 4541.
6. Hirsch C S, Ellner J J, Russell D G & Rich E A, Complement receptor-mediated uptake and tumor necrosis factor-alphamediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages, J Immunol, 152 (1994) 743.
7. Schlesinger L S, Bellinger-Kawahara C S, Payne N R & Horwitz M A, Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3, J Immunol, 144 (1990) 2771.
8. Ramanathan V D, Curtis J & Turk J L, Activation of the alternative pathway of complement by mycobacteria and cord factor, Infect Immun, 29 (1980) 30.
9. Ramanathan V D, Parkash O, Tyagi P, Sengupta U & Ramu G, Activation of the human complement system by phenolic glycolipid 1 of Mycobacterium leprae, Microb Pathog, 8 (1990) 403.
10. Parkash O, Ramanathan V D, Singh, D P & Sengupta U, Activation of the alternative pathway of the complement system by mycobacteria, Curr Sci, 56 (1987) 968.
11. Parkash O, Ramanathan V D, Singh D P & Sengupta U, Effect of anti-mycobacterial antibodies on activation of the alternative pathway of the human complement system, FEMS Microbiol Lett, 55 (1998) 255.
12. Hoft D F, Kemp E B, Marinaro M, Cruz O, Kiyono H, McGhee J R, Belisle J T, Milligan T W, Miller J P & Belshe R B, A double-blind, placebo-controlled study of Mycobacteriumspecific human immune responses induced by intradermal bacille Calmette-Guerin vaccination, J Lab Clin Med, 134 (1999) 244.
13. Brown R M, Cruz O, Brennan M, Gennaro M L, Schlesinger L, Skeiky Y A & Hoft D F, Lipoarabinomannan-reactive human secretory IgA responses induced by mucosal bacille Calmette-Guerin vaccination, J Infect Dis, 187 (2003) 513.
14. Teitelbaum R, Glatman-Freedman A, Chen B, Robbins J B, Unanue E, Casadevall A & Bloom B R, A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival, Proc Natl Acad Sci USA, 95 (1998) 15688.
15. Hamasur B, Haile M, Pawlowski A, Schroder U, Williams A, Hatch G, Hall G, Marsh P, Kallenius G & Svenson S B, Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis, Vaccine, 21(2003) 4081.
16. de Valliere S, Abate G, Blazevic A, Heuertz R M & Hoft D F, Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies, Infect Immun, 73 (2005) 6711.
17. Joller N, Webera S S, Müllera A J, Spörria R, Selchowb P, Sanderb P, Hilbic H, et al, Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting, Proc Natl Acad Sci USA, 107 (2010) 20441.
18. Selvakumar N, Vanajakumar S, Gopi P G, Venkataramu K V, Datta M, Paramasivan C N & Prabhakar R, Isolation of tubercle bacilli from sputum samples of patients in the Weld studies by the cetylpyridinium chloride-sodium chloride and sodium hydroxide methods, Indian J Med Res, 102 (1995) 149.
19. Imaz M S & Zerbini E, Antibody response to culture filtrate antigens of Mycobacterium tuberculosis during and after treatment of tuberculosis patients, Int J Tuberc Lung Dis, 4 (2000) 562.
20. Cox R A, Britt L A & Michael R A, Isolation of Coccidioides immitis F antigen by immunoaffinity chromatography with monospecific antiserum, Infect Immun, 55 (1987) 227.
21. Towbin H, Staehactin T & Godon G, Electrophoretic transfer of proteins from poly acryl amide gel to nitrocellulose sheets, procedures and some applications, Proc Natl Acad Med Sci USA, 76 (1979) 4350.
22. +) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages, J Exp Med, 191 (2000) 287.
23. Silver R F, Li Q & Ellner J J, Expression of virulence of Mycobacterium tuberculosis within human monocytes: Virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions, Infect Immun, 66 (1998) 1190.
24. Kamala T, Paramasivan C N, Herbert D, Venkatesan P & Prabhakar R, Immune response & modulation of immune response induced in the guinea-pigs by Mycobacterium avium complex (MAC) & M. fortuitum complex isolates from different sources in the south Indian BCG trial area, Indian J Med Res, 103 (1996) 201.
25. Brandt L, Cunha J F, Olsen A W, Chilima B, Hirsch P, Appelberg R & Andersen P, Failure of the Mycobacterium bovis BCG Vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis, Infect Immun, 70 (1992) 672.
26. Narayanan S, Paramasivan C N, Ravoof A, Narayanan P R & Prabhakar R, Sensitization pattern of healthy volunteers and tuberculous patients to various mycobacterial antigens by ELISA, Indian J Tuberc, 34 (1987) 132.
27. Herbert D, Paramasivan C N, Datta M, Vallishayee R S & Prabhakar R, IgG antibodies against antigens of various mycobacterial species in children and in pre and post-BCG young adults, Indian J Tuberc, 42 (1995) 15.
28. Glatman-Freedman A & Casadevall A, Serum therapy for tuberculosis revisited: reappraisal of the role of antibodymediated immunity against Mycobacterium tuberculosis, Clin Microbiol Rev, 11 (1998) 514.
29. Joiner K A, Fries L F & Frank M M, Studies of antibody and complement function in host defense against bacterial infection, Immunol Lett, 14 (1987) 197.
30. Brown E J, Complement receptors, adhesion, and phagocytosis, Infect Agents Dis, 1 (1992) 63.
31. Ofek I, Goldhar J, Keisari Y & Sharon N, Nonopsonic phagocytosis of microorganisms, Annu Rev Microbiol, 49 (1995) 239.
32. Hostetter J, Kagan R & Steadham E, Opsonization effects on Mycobacterium avium subsp. paratuberculosis--macrophage interactions, Clin Diagn Lab Immunol, 12 (2005) 793.
33. Jenkin C R & Rowley D, Basis for immunity to typhoid in mice and the question of "Cellular Immunity", Bacteriol Rev, 27 (1963) 391.
34. Delibrias C C, Kazatchkine M D, Fischer E, Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV, Scand J Immunol, 38 (1993) 183.
35. Stoiber H, Kacani L, Speth C, Wurzner R & Dierich M P, The supportive role of complement in HIV pathogenesis, Immunol Rev, 187 (2001) 168.
36. Hu C, Mayadas-Norton T, Tanaka K, Chan J & Salgame P, Mycobacterium tuberculosis infection in complement receptor 3-deficient mice, J Immunol, 165 (2000) 2596.
37. Wright S D & Silverstein S C, Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes, J Exp Med, 158 (1983) 2016.